曲海晶，东北林业大学与加州大学戴维斯分校联合培养博士，上海交通大学博士后。主要科研方向为响应性纳米药物递送系统的构建及疾病免疫调控治疗。近 5 年以第一或共一作者在 ACS Nano、Biomaterials、Journal of Controlled Release、Acta Biomaterialia 等学术期刊发表论文十余篇，H因子11。相关工作申请国家发明专利 3 项。 担任《Exploration》2024届青年编委，《Nano TransMed》第二届青年编委。为《Journal of Nanobiotechnology》,《International Journal of Nanomedicine》等期刊审稿人。
论文：
11. Qu, H.; Wu, J.; Pan, Y.; Abdulla, A.; Duan, Z.; Cheng, W.; Wang, N.; Chen, H.; Wang, C.; Yang, J.; Tang, J.; Yang, C.; Wu, C.*; Xue, X.*, Biomimetic Nanomodulator Regulates Oxidative and Inflammatory Stresses to Treat Sepsis-Associated Encephalopathy. ACS Nano 2024, 18, 41, 28228–28245 doi: 10.1021/acsnano.4c08157. IF=15.8
10. Chen, H.†; Qu, H.† *; Pan, Y.; Cheng, W.; Xue, X*. Manganese-coordinated nanoparticle with high drug-loading capacity and synergistic photo-/immuno-therapy for cancer treatments. Biomaterials, 2025, 312, 122745. IF=12.8
9. Haijing Qu; Longmeng Li et.al Drug-drug conjugates self-assembled nanomedicines triggered photo-/immuno- therapy for synergistic cancer treatments. Journal of Controlled Release, 2023, 363, 361-375.
8. Haijing Qu; Hai Chen et.al Charge-Reversible Crosslinked Nanoparticle for Improved Pro-Apoptotic Peptide Delivery and Synergistic Photodynamic Cancer Therapy. Nano Research, 2023 doi: 10.1007/s12274-023-5912-7.
7. Haijing Qu, Jinfan Yang, Shuaijun Li, et.al Programmed-response cross-linked nanocarrier for multidrug-resistant ovarian cancer treatment. Journal of Controlled release, 2023, 357, 274-286. IF=11.467. 中科院 1 区
6. Xiangdong Xue1, Haijing Qu1, Ruonan Bo1 et.al A Transformable Nanoplatform with Multiple Therapeutic and Immunostimulatory Properties for Treatment of Advanced Cancers. Biomaterials 2023, 299, 122145. IF=15.03. 中科院 1 区
5. Haijing Qu et.al A Supramolecular Assembly Strategy for Hydrophilic Drug Delivery towards Synergistic Cancer Treatment. Acta Biomaterialia, 2023, 164, 407. IF=10.633. 中科院 1 区
4. Haijing Qu et.al, Uncovering the Fate and Risks of Intravenously injected Prussian Blue Nanoparticles in mice by an Integrated Methodology of Toxicology, Pharmacokinetics, Proteomics and Metabolomics. Particle and Fibre Toxicology, 2023, Accepted. IF=9.112. 中科院 1 区
3. Ying Zhang1; Haijing Qu1; Xue, X.*, Blood-brain barrier penetrating liposomes with synergistic chemotherapy for glioblastoma treatment. Biomaterials Science 2022, 10 (2), 423-434. IF=7.59. 中科院 2区
2. Lijia Jing1, Haijing Qu1, Dongqi Wu, et al. Platelet-camouflaged nanococktail: Simultaneous inhibition of drug-resistant tumor growth and metastasis via cancer cells and tumor vasculature dual-targeting strategy. Theranostics. 2018, 8(10): 2683-2695. (中科院 1 区 top，IF =11.556，共一，副导师第一位)
1. Haijing Qu, Mingzhu Zhang, Yan Chen, et al. Freeze-drying of liposomal nanohybrid cerasomes with cryoprotectants: In vitro and in vivo evaluation. Drying Technology. 2018, 36(9): 1041–1048. (中科院 3 区，IF 2.988)